| Anti-inflammatory small molecules to treat seizures and epilepsy: from bench to bedside A Dey, X Kang, J Qiu, Y Du, J Jiang Trends in pharmacological sciences 37 (6), 463-484, 2016 | 225 | 2016 |
| Cyclooxygenase-2 in glioblastoma multiforme J Qiu, Z Shi, J Jiang Drug discovery today 22 (1), 148-156, 2017 | 138 | 2017 |
| Recent advances in anticancer activities and drug delivery systems of tannins Y Cai, J Zhang, NG Chen, Z Shi, J Qiu, C He, M Chen Medicinal Research Reviews 37 (4), 665-701, 2017 | 110 | 2017 |
| Piperlongumine induces apoptosis and synergizes with cisplatin or paclitaxel in human ovarian cancer cells LH Gong, XX Chen, H Wang, QW Jiang, SS Pan, JG Qiu, XL Mei, YQ Xue, ... Oxidative medicine and cellular longevity 2014 (1), 906804, 2014 | 98 | 2014 |
| A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population Y Qu, J Feng, X Wu, L Bai, W Xu, L Zhu, Y Liu, F Xu, X Zhang, G Yang, ... Nature communications 13 (1), 2052, 2022 | 91 | 2022 |
| Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo XL Mei, Y Yang, YJ Zhang, Y Li, JM Zhao, JG Qiu, WJ Zhang, QW Jiang, ... American journal of cancer research 5 (11), 3311, 2015 | 91 | 2015 |
| Prostaglandin E2 signaling: alternative target for glioblastoma? J Jiang, J Qiu, Q Li, Z Shi Trends in cancer 3 (2), 75-78, 2017 | 76 | 2017 |
| Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter JG Qiu, YJ Zhang, Y Li, JM Zhao, WJ Zhang, QW Jiang, XL Mei, YQ Xue, ... Oncotarget 6 (17), 15494, 2015 | 72 | 2015 |
| Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer XX Chen, FF Xie, XJ Zhu, F Lin, SS Pan, LH Gong, JG Qiu, WJ Zhang, ... Oncotarget 6 (17), 14926, 2015 | 71 | 2015 |
| Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752 XX Chen, LH Gong, RY Ou, ZZ Zheng, JY Chen, FF Xie, XX Huang, ... Gynecologic oncology 140 (3), 537-544, 2016 | 69 | 2016 |
| Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine QW Jiang, KJ Cheng, XL Mei, JG Qiu, WJ Zhang, YQ Xue, WM Qin, ... Oncotarget 6 (32), 32790, 2015 | 67 | 2015 |
| Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype X Kang, J Qiu, Q Li, KA Bell, Y Du, DW Jung, JY Lee, J Hao, J Jiang Scientific reports 7 (1), 9459, 2017 | 61 | 2017 |
| Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing Y Yang, JG Qiu, Y Li, JM Di, WJ Zhang, QW Jiang, DW Zheng, Y Chen, ... American Journal of Translational Research 8 (9), 3986, 2016 | 57 | 2016 |
| Small‐molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase‐associated malignant glioma growth J Qiu, Q Li, KA Bell, X Yao, Y Du, E Zhang, JJ Yu, Y Yu, Z Shi, J Jiang British journal of pharmacology 176 (11), 1680-1699, 2019 | 55 | 2019 |
| MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1 P Li, Y Yang, H Liu, AK Yang, JM Di, GM Tan, HF Wang, JG Qiu, ... Journal of hematology & oncology 10, 1-4, 2017 | 50 | 2017 |
| Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer Y Luo, QW Jiang, JY Wu, JG Qiu, WJ Zhang, XL Mei, Z Shi, JM Di Oncotarget 6 (26), 22564, 2015 | 47 | 2015 |
| Nanoscale drug delivery for taxanes based on the mechanism of multidrug resistance of cancer S Wang, J Qiu, Z Shi, Y Wang, M Chen Biotechnology Advances 33 (1), 224-241, 2015 | 45 | 2015 |
| Integration of nanomaterials with nucleic acid amplification approaches for biosensing Z Wang, P Li, L Cui, JG Qiu, BH Jiang, C Zhang TrAC Trends in Analytical Chemistry 129, 115959, 2020 | 43 | 2020 |
| Apigenin inhibits IL-6 transcription and suppresses esophageal carcinogenesis JG Qiu, L Wang, WJ Liu, JF Wang, EJ Zhao, FM Zhou, XB Ji, LH Wang, ... Frontiers in pharmacology 10, 1002, 2019 | 41 | 2019 |
| Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus Y Du, T Kemper, J Qiu, J Jiang Expert review of neurotherapeutics 16 (2), 123-130, 2016 | 40 | 2016 |
